Clinical risk scoring system for predicting extended-spectrum β-lactamase-producing Escherichia coli infection in hospitalized patients

Journal of Hospital Infection

Volumn 93, Issue 1, 2016, Pages 49-56

  Kengkla, K ^a   Charoensuk, N ^a   Chaichana, M ^a   Puangjan, S ^a   Rattanapornsompong, T ^a   Choorassamee, J ^a   Wilairat, P ^a   Saokaew, S ^a  

^a UNIVERSITY OF PHAYAO   (Thailand)

Author keywords

Clinical prediction rule; Escherichia coli; Extended spectrum lactamase; Risk scoring system

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN; PRESCRIPTION DRUG; ANTIINFECTIVE AGENT; BETA LACTAMASE;

ADULT; AGE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; CALIBRATION; CLINICAL RISK SCORING SYSTEM; CONTROLLED STUDY; ESCHERICHIA COLI INFECTION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FEMALE; GENDER; HEALTHCARE ASSOCIATED INFECTION; HOSPITAL INFECTION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INFECTION RISK; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREDICTION; PRESCRIPTION; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; SEPSIS; ADOLESCENT; AGED; DECISION SUPPORT SYSTEM; ENZYMOLOGY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; MICROBIOLOGY; MIDDLE AGED; SECRETION (PROCESS); YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; DECISION SUPPORT TECHNIQUES; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; YOUNG ADULT;

EID: 84958580893     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2016.01.007     Document Type: Article

References (25)

1. Morrissey I., Hackel M., Badal R., Bouchillon S., Hawser S., Biedenbach D. A review of ten years of the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2002 to 2011. Pharmaceuticals (Basel) 2013, 6:1335-1346.
2. Paterson D.L., Bonomo R.A. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 2005, 18:657-686.
3. Thaden J.T., Fowler V.G., Sexton D.J., Anderson D.J. Increasing incidence of extended-spectrum beta-lactamase-producing Escherichia coli in community hospitals throughout the southeastern United States. Infect Control Hosp Epidemiol 2016, 37:49-54.
4. Giske C.G., Monnet D.L., Cars O., Carmeli Y. Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother 2008, 52:813-821.
5. Maslikowska J.A., Walker S.A., Elligsen M., et al. Impact of infection with extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella species on outcome and hospitalization costs. J Hosp Infect 2016, 92:33-41.
6. Anunnatsiri S., Towiwat P., Chaimanee P. Risk factors and clinical outcomes of extended spectrum beta-lactamase (ESBL)-producing Escherichia coli septicemia at Srinagarind University Hospital, Thailand. Southeast Asian J Trop Med Public Health 2012, 43:1169-1177.
7. Rawat D., Nair D. Extended-spectrum beta-lactamases in Gram negative bacteria. J Glob Infect Dis 2010, 2:263-274.
8. Pitout J.D., Laupland K.B. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008, 8:159-166.
9. Daroukh A., Delaunay C., Bigot S., et al. Characteristics and costs of carbapenemase-producing enterobacteria carriers (2012/2013). Med Mal Infect 2014, 44:321-326.
10. Dautzenberg M.J., Wekesa A.N., Gniadkowski M., et al. The association between colonization with carbapenemase-producing enterobacteriaceae and overall ICU mortality: an observational cohort study. Crit Care Med 2015, 43:1170-1177.
11. Schwaber M.J., Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother 2007, 60:913-920.
12. Nordmann P., Naas T., Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 2011, 17:1791-1798.
13. Yang Y.S., Ku C.H., Lin J.C., et al. Impact of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae on the outcome of community-onset bacteremic urinary tract infections. J Microbiol Immunol Infect 2010, 43:194-199.
14. Goulenok T., Ferroni A., Bille E., et al. Risk factors for developing ESBL E. coli: can clinicians predict infection in patients with prior colonization?. J Hosp Infect 2013, 84:294-299.
15. Tumbarello M., Trecarichi E.M., Bassetti M., et al. Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system. Antimicrob Agents Chemother 2011, 55:3485-3490.
16. Johnson S.W., Anderson D.J., May D.B., Drew R.H. Utility of a clinical risk factor scoring model in predicting infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae on hospital admission. Infect Control Hosp Epidemiol 2013, 34:385-392.
17. Drawz S.M., Porter S., Kuskowski M.A., et al. Variation in resistance traits, phylogenetic backgrounds, and virulence genotypes among Escherichia coli clinical isolates from adjacent hospital campuses serving distinct patient populations. Antimicrob Agents Chemother 2015, 59:5331-5339.
18. Pitout J.D. Infections with extended-spectrum beta-lactamase-producing Enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs 2010, 70:313-333.
19. Siegman-Igra Y., Fourer B., Orni-Wasserlauf R., et al. Reappraisal of community-acquired bacteremia: a proposal of a new classification for the spectrum of acquisition of bacteremia. Clin Infect Dis 2002, 34:1431-1439.
20. Cardoso T., Almeida M., Friedman N.D., et al. Classification of healthcare-associated infection: a systematic review 10 years after the first proposal. BMC Med 2014, 12:40.
21. Bone R.C., Balk R.A., Cerra F.B., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655.
22. Dellinger R.P., Levy M.M., Rhodes A., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013, 41:580-637.
23. Steyerberg E.W., Vickers A.J., Cook N.R., et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology 2010, 21:128-138.
24. Slekovec C., Bertrand X., Leroy J., Faller J.P., Talon D., Hocquet D. Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission is not that simple. Antimicrob Agents Chemother 2012, 56:2218-2219. author reply 2220.
25. van Griensven J., Florence E., Van den Ende J. Validation of clinical scores for risk assessment. Clin Infect Dis 2012, 54:1520-1521.